Research News
View articles by month and year
-
Ten Years of Tamoxifen Better Than Five for Early-Stage, Estrogen-Receptor-Positive Disease
For women diagnosed with early-stage, estrogen-receptor-positive breast cancer, 10 years of tamoxifen offers more benefits than 5 years.
-
Radiation Therapy Benefits Older Women Diagnosed with Early Stage Breast Cancer
Many older women benefit from radiation therapy after lumpectomy to remove early-stage breast cancer.
-
Certain Jobs Seem to Increase Breast Cancer Risk
A Canadian study suggests that certain jobs, including those in farming and manufacturing that expose women to high levels of carcinogens and endocrine disrupters, seem to increase breast cancer risk.
-
Adding Digital Tomosynthesis to Digital Mammography Improves Radiologists’ Accuracy
A study has found that when radiologists looked at digital tomosynthesis images along with digital mammogram images, they were more accurate and had lower false positive recall rates compared to radiologists who looked only at digital mammograms.
-
Reflexology Helps Ease Chemo, Hormonal Therapy Side Effects
A study has found that reflexology helped ease some side effects from chemotherapy and hormonal therapy treatments in women being treated for metastatic breast cancer.
-
Aerobic Exercise Helps Ease Cancer-Related Fatigue
A new review of studies on exercise and cancer-related fatigue adds more and stronger evidence that aerobic exercise can help relieve fatigue associated with cancer and cancer treatment.
-
Heart Problems Happen More Often Than Thought in Older Women After Herceptin Treatment
A large study has found that older women diagnosed with early-stage, HER2-positive breast cancer treated with Herceptin have a higher risk of heart failure than women who didn’t get Herceptin.
-
Quality Personal Relationships Boost Survival in Women Diagnosed with Early-Stage Breast Cancer
A study suggests that the quality of a woman’s social networks seems to be just as important as the size of the social networks in predicting breast cancer survival.
-
Radiation Therapy for Breast Cancer Doesn’t Seem to Increase Risk of Heart Problems
A study with more than two decades of follow-up suggests that women who have lumpectomy and radiation therapy don’t have a higher risk of heart problems than women who have mastectomy.
-
T-DM1 Granted Priority Review by FDA
The U.S. Food and Drug Administration has granted priority review to T-DM1 to treat HER2-positive, metastatic breast cancer.
